Pursuant to Reg.39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed that the Company has received request for issue of Duplicate Share Certificate against the Certificate reported to be lost/misplaced as per the details enclosed.
The above information is a part of company’s filings submitted to BSE.